private:nextdimensionned
|
461305
|
May 30th, 2019 12:00AM
|
NeD (Next Dimension) LTD
|
19
|
4.00
|
Open
|
Medical Devices
|
May 30th, 2019 02:15PM
|
May 30th, 2019 02:15PM
|
NeD (Next Dimension) is developing the next generation of retinal imaging systems, which utilize spectral imaging to map metabolic activity in the retina that can provide an early warning prior to the onset of noticeable anatomic tissue damage followed by vision loss.The system will be used as part of the routine practice to diagnose and monitor the treatment of patients suffering from vision threatening diseases such as Diabetic Retinopathy, AMD and Glaucoma.
|
Open
|
|
Open
|
|
|
|
IL
|
|
|
Next Dimension (NeD)
|
Health Care
|
Pharmaceuticals & Biotechnology
|
private:nextdimensionned
|
461305
|
Mar 23rd, 2018 12:00AM
|
NeD (Next Dimension) LTD
|
19
|
4.00
|
Open
|
Medical Devices
|
Mar 23rd, 2017 10:51AM
|
Mar 23rd, 2017 10:51AM
|
NeD (Next Dimension) is developing the next generation of retinal imaging systems, which utilize spectral imaging to map metabolic activity in the retina that can provide an early warning prior to the onset of noticeable anatomic tissue damage followed by vision loss.The system will be used as part of the routine practice to diagnose and monitor the treatment of patients suffering from vision threatening diseases such as Diabetic Retinopathy, AMD and Glaucoma.
|
|
|
|
|
|
|
|
|
|
Next Dimension (NeD)
|
Health Care
|
Pharmaceuticals & Biotechnology
|
private:nextdimensionned
|
461305
|
Feb 17th, 2018 12:00AM
|
NeD (Next Dimension) LTD
|
19
|
4.00
|
Open
|
Medical Devices
|
Feb 17th, 2018 02:25PM
|
Feb 17th, 2018 02:25PM
|
NeD (Next Dimension) is developing the next generation of retinal imaging systems, which utilize spectral imaging to map metabolic activity in the retina that can provide an early warning prior to the onset of noticeable anatomic tissue damage followed by vision loss.The system will be used as part of the routine practice to diagnose and monitor the treatment of patients suffering from vision threatening diseases such as Diabetic Retinopathy, AMD and Glaucoma.
|
|
|
|
|
|
|
|
|
|
Next Dimension (NeD)
|
Health Care
|
Pharmaceuticals & Biotechnology
|
private:nextdimensionned
|
461305
|
Feb 16th, 2018 12:00AM
|
NeD (Next Dimension) LTD
|
19
|
4.00
|
Open
|
Medical Devices
|
Feb 16th, 2017 08:15AM
|
Feb 16th, 2017 08:15AM
|
NeD (Next Dimension) is developing the next generation of retinal imaging systems, which utilize spectral imaging to map metabolic activity in the retina that can provide an early warning prior to the onset of noticeable anatomic tissue damage followed by vision loss.The system will be used as part of the routine practice to diagnose and monitor the treatment of patients suffering from vision threatening diseases such as Diabetic Retinopathy, AMD and Glaucoma.
|
|
|
|
|
|
|
|
|
|
Next Dimension (NeD)
|
Health Care
|
Pharmaceuticals & Biotechnology
|
private:nextdimensionned
|
461305
|
Feb 15th, 2018 12:00AM
|
NeD (Next Dimension) LTD
|
19
|
4.00
|
Open
|
Medical Devices
|
Feb 15th, 2017 10:07AM
|
Feb 15th, 2017 10:07AM
|
NeD (Next Dimension) is developing the next generation of retinal imaging systems, which utilize spectral imaging to map metabolic activity in the retina that can provide an early warning prior to the onset of noticeable anatomic tissue damage followed by vision loss.The system will be used as part of the routine practice to diagnose and monitor the treatment of patients suffering from vision threatening diseases such as Diabetic Retinopathy, AMD and Glaucoma.
|
|
|
|
|
|
|
|
|
|
Next Dimension (NeD)
|
Health Care
|
Pharmaceuticals & Biotechnology
|
private:nextdimensionned
|
461305
|
Feb 14th, 2018 12:00AM
|
NeD (Next Dimension) LTD
|
19
|
4.00
|
Open
|
Medical Devices
|
Feb 14th, 2017 01:50PM
|
Feb 14th, 2017 01:50PM
|
NeD (Next Dimension) is developing the next generation of retinal imaging systems, which utilize spectral imaging to map metabolic activity in the retina that can provide an early warning prior to the onset of noticeable anatomic tissue damage followed by vision loss.The system will be used as part of the routine practice to diagnose and monitor the treatment of patients suffering from vision threatening diseases such as Diabetic Retinopathy, AMD and Glaucoma.
|
|
|
|
|
|
|
|
|
|
Next Dimension (NeD)
|
Health Care
|
Pharmaceuticals & Biotechnology
|
private:nextdimensionned
|
461305
|
Feb 13th, 2018 12:00AM
|
NeD (Next Dimension) LTD
|
19
|
4.00
|
Open
|
Medical Devices
|
Feb 13th, 2017 04:11PM
|
Feb 13th, 2017 04:11PM
|
NeD (Next Dimension) is developing the next generation of retinal imaging systems, which utilize spectral imaging to map metabolic activity in the retina that can provide an early warning prior to the onset of noticeable anatomic tissue damage followed by vision loss.The system will be used as part of the routine practice to diagnose and monitor the treatment of patients suffering from vision threatening diseases such as Diabetic Retinopathy, AMD and Glaucoma.
|
|
|
|
|
|
|
|
|
|
Next Dimension (NeD)
|
Health Care
|
Pharmaceuticals & Biotechnology
|
private:nextdimensionned
|
461305
|
Feb 12th, 2018 12:00AM
|
NeD (Next Dimension) LTD
|
19
|
4.00
|
Open
|
Medical Devices
|
Feb 12th, 2017 04:15AM
|
Feb 12th, 2017 04:15AM
|
NeD (Next Dimension) is developing the next generation of retinal imaging systems, which utilize spectral imaging to map metabolic activity in the retina that can provide an early warning prior to the onset of noticeable anatomic tissue damage followed by vision loss.The system will be used as part of the routine practice to diagnose and monitor the treatment of patients suffering from vision threatening diseases such as Diabetic Retinopathy, AMD and Glaucoma.
|
|
|
|
|
|
|
|
|
|
Next Dimension (NeD)
|
Health Care
|
Pharmaceuticals & Biotechnology
|
private:nextdimensionned
|
461305
|
Feb 11th, 2018 12:00AM
|
NeD (Next Dimension) LTD
|
19
|
4.00
|
Open
|
Medical Devices
|
Feb 11th, 2017 05:35AM
|
Feb 11th, 2017 05:35AM
|
NeD (Next Dimension) is developing the next generation of retinal imaging systems, which utilize spectral imaging to map metabolic activity in the retina that can provide an early warning prior to the onset of noticeable anatomic tissue damage followed by vision loss.The system will be used as part of the routine practice to diagnose and monitor the treatment of patients suffering from vision threatening diseases such as Diabetic Retinopathy, AMD and Glaucoma.
|
|
|
|
|
|
|
|
|
|
Next Dimension (NeD)
|
Health Care
|
Pharmaceuticals & Biotechnology
|
private:nextdimensionned
|
461305
|
Feb 10th, 2018 12:00AM
|
NeD (Next Dimension) LTD
|
19
|
4.00
|
Open
|
Medical Devices
|
Feb 10th, 2017 06:43AM
|
Feb 10th, 2017 06:43AM
|
NeD (Next Dimension) is developing the next generation of retinal imaging systems, which utilize spectral imaging to map metabolic activity in the retina that can provide an early warning prior to the onset of noticeable anatomic tissue damage followed by vision loss.The system will be used as part of the routine practice to diagnose and monitor the treatment of patients suffering from vision threatening diseases such as Diabetic Retinopathy, AMD and Glaucoma.
|
|
|
|
|
|
|
|
|
|
Next Dimension (NeD)
|
Health Care
|
Pharmaceuticals & Biotechnology
|